These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 20585321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian Twin Cities ROP screening (ITCROPS) data base report number 7.
    Chhablani J, Rani PK, Balakrishnan D, Jalali S.
    Semin Ophthalmol; 2014 Jul; 29(4):222-5. PubMed ID: 24117452
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series.
    Dani C, Frosini S, Fortunato P, Bertini G, Pratesi S, Pollazzi L, Caputo R, La Torre A.
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2194-7. PubMed ID: 22506618
    [Abstract] [Full Text] [Related]

  • 4. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity.
    Kychenthal A, Dorta P.
    Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.
    Mintz-Hittner HA, Kuffel RR.
    Retina; 2008 Jun; 28(6):831-8. PubMed ID: 18536599
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.
    Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D.
    Retina; 2011 Jun; 31(7):1239-47. PubMed ID: 21555969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
    Dorta P, Kychenthal A.
    Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story.
    Quiroz-Mercado H, Ustariz-González O, Martinez-Castellanos MA, Covarrubias P, Dominguez F, Sanchez-Huerta V.
    Semin Ophthalmol; 2007 Apr; 22(2):109-25. PubMed ID: 17564934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
    Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, Fujikado T.
    Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA.
    Retina; 2007 Nov; 27(9):1187-95. PubMed ID: 18046223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.